New combo therapy to be listed

pharmacist pharmacy medicines meds pills
A new combination therapy for type 2 diabetes, which can be prescribed alongside metformin, is set to be listed on the PBS from 1 April Glyxambi, a new oral, fixed-dose combination of the SGLT2 empagliflozin inhibitor (Jardiance) and DPP4 inhibitor linagliptin (Trajenta) will become available on the PBS from 1 April 2018. Glyxambi (empagliflozin/linagliptin) can

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Recognising service on transfer of business
Next Blockbuster alert